Isolation, purification and biological activity of major docetaxel metabolites from human feces

Drug Metabolism and Disposition

Volumn 24, Issue 6, 1996, Pages 655-658

  Sparreboom, Alex ^a   Van Tellingen, Olaf ^a   Scherrenburg, Esther J ^a   Boesen, Jan J B ^b   Huizing, Manon T ^c   Nooijen, Willem J ^a   Versluis, Cornelis ^d   Beijnen, Jos H ^c,d  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DRUG METABOLITE;

ANIMAL CELL; ARTICLE; BONE MARROW SUPPRESSION; CANCER CELL CULTURE; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG OXIDATION; DRUG PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FECES; FEMALE; HUMANS; PACLITAXEL; TAXOIDS;

ANIMALIA;

EID: 0030039615     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. M. Colin, D. Guénard, F. Guéritte-Voegelein, and P. Potier: Taxol derivatives, their preparation and pharmaceutical conditions containing them. U.S. Patent 4814470 (granted March 21, 1989; priority date, July 17, 1986).
2. I. Ringel and S. B. Horwitz: Studies with RP 56976 (Taxotere): a semi-synthetic analogue of taxol. J. Natl. Cancer Inst. 83, 288-291 (1991).
3. M. T. Huizing, V. H. Sewberath Misser, R. C. Pieters, W. W. ten Bokkel Huinink, C. H. N. Veenhof, J. B. Vermorken, H. M. Pinedo, and J. H. Beijnen: Taxanes: a new class of antitumor agents. Cancer Invest. 13, 381-404 (1995).
4. 14C-RP56976) in mice and dogs. Proc. Am. Assoc. Cancer Res. 34, 393 (abstr.) (1993).
5. ®) metabolism in the rat in vivo and in vitro. Proc. Am. Assoc. Cancer Res. 35, 410 (abstr.) (1994).
6. 14 radiolabelled Taxotere (TXT) (RP56976, NSC628503) in cancer patients. Proc. Am. Assoc. Cancer Res. 34, 373 (abstr.) (1993).
7. X. R. Zhou-Pan, F. Marre, X. J. Zhou, T. Gaulthier, M. Placidi, and R. Rahmani: Preliminary characterization of taxotere metabolism by using human liver microsomal fractions. Cell. Pharmacol. 1, S119 (abstr.) (1993).
8. T. Cresteil, B. Monsarrat, I. Royer, and M. Wright: Metabolism of docetaxel by human cytochromes P450. Interactions with paclitaxel and other antineoplastic drugs. Proc. Am. Assoc. Cancer Res. 36, 395 (abstr.) (1995).
9. ®). Tetrahedron Lett. 35, 3715-3718 (1994).
10. A. Commerçon, J. D. Bourzat, D. Bézard, and M. Vuilhorgne: Partial synthesis of major human metabolites of docetaxel. Tetrahedron 50, 10289-10298 (1994).
11. A. Sparreboom, M. T. Huizing, J. J. B. Boesen, W. J. Nooijen, O. van Tellingen, and J. H. Beijnen: Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces. Cancer Chemother. Pharmacol. 36, 299-304 (1995).
12. V. W. van Beusechem, A. Kukler, P. J. Heidt, and D. Valerio: Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone marrow cells. Proc. Natl. Acad. Sci. U.S.A. 89, 7640-7646 (1992).
13. A. Sparreboom, O. Van Tellingen, W. J. Nooijen, and J. H. Beijnen: Tissue distribution, metabolism and excretion of paclitaxel and mice. Anti-Cancer Drugs 7, 78-86 (1996).
14. B. Monsarrat, P. Alvinerie, M. Wright, J. Dubois, F. Guéritte-Voeglein, D. Guénard, R. C. Donehower, and E. K. Rowinsky: Hepatic metabolism and biliary clearance of taxol in rats and humans. J. Natl. Cancer Inst. Monogr. 15, 39-46 (1993).
15. T. Cresteil, B. Monsarrat, P. Alvinerie, J. M. Treluyer, I. Vieira, and M. Wright: Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res. 54, 386-392 (1994).
16. J. W. Harris, A. Rahman, B.-R. Kim, F. P. Guengerich, and J. M. Collins: Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res. 54, 4026-4035 (1994).
17. A. Rahman, K. R. Koczekwa, J. Grogan, J. Gonzalez, and J. W. Harris: Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54, 5543-5546 (1994).
18. J. W. Harris, A. Katki, L. W. Anderson, G. N. Chmurny, I. V. Paukstelis, and J. M. Collins: Isolation, structural determination, and biological activity of 6aα-hydroxytaxol, the principal human metabolite of taxol. J. Med. Chem. 37, 706-710 (1993).
19. G. N. Kumar, J. E. Oatis, K. R. Thornburg, H. J. Heldrich, E. Starr Hazard III, and T. Walle: 6α-Hydroxytaxol: isolation and identification of the major metabolite of taxol in human liver microsomes. Drug Metab. Dispos. 22, 177-179 (1993).